STANGER KENT W 4

Accession 0001179110-17-014791

CIK 0000856982other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 6:46 PM ET

Size

21.3 KB

Accession

0001179110-17-014791

Form 4

Period: 2017-11-29

DirectorChief Financial Officer

Transactions

Exercise/Conversion
Common Stock, No Par Value
2017-11-30$13.75/sh+700$9,625→ 412,234 total
Sale
Common Stock, No Par Value
2017-11-29$44.57/sh−2,218$98,856→ 411,534 total
Sale
Common Stock, No Par Value
2017-11-30$44.50/sh−700$31,150→ 411,534 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2017-11-29−2,218→ 51,782 total
Exercise: $13.75From: 2012-08-11Exp: 2018-08-11→ Common Stock (2,218 underlying)
Exercise/Conversion
Common Stock, No Par Value
2017-11-29$13.75/sh+2,218$30,498→ 413,752 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2017-11-30−700→ 51,082 total
Exercise: $13.75From: 2012-08-11Exp: 2018-08-11→ Common Stock (700 underlying)

Holdings

Common Stock, No Par Value
(indirect: By 401(k))
42,277
Common Stock, No Par Value
(indirect: Family Limited Liability Company)
29,524
Common Stock, No Par Value
4,271
Non-qualified stock options (right to buy)
Exercise: $12.06From: 2015-10-04Exp: 2021-10-04→ Common Stock (2,000 underlying)
2,000
Non-qualified stock options (right to buy)
Exercise: $34.40From: 2018-05-24Exp: 2024-05-24→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $18.80From: 2017-05-26Exp: 2023-05-26→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $19.72From: 2017-05-02Exp: 2023-05-02→ Common Stock (9,375 underlying)
9,375

Footnotes (9)

[F1]Represents plan holdings as of 11/30/2017.
[F2]Employee stock purchase plan holdings as of 11/30/2017.
[F3]This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC.
[F4]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.50 to $44.70, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F5]Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012.
[F6]Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
[F7]Becomes exercisable in equal annual installments of 20% commencing on 05/02/2017.
[F8]Becomes exercisable in equal annual installments of 20% commencing on 05/26/2017.
[F9]Becomes exercisable in equal annual installments of 20% commencing on 05/24/2018.

Documents

1 file

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother